Teleflex Incorporated (TFX) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $125.21. It has a SharesGrow Score of 48/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of TFX = $142.15 (+13.5% from the current price, the stock appears fairly valued). Analyst consensus target is TFX = $133 (+6.4% upside).
Valuation: TFX trades at a trailing Price-to-Earnings (P/E) of -5.9 (S&P 500 average ~25).
Financials: revenue is $2.0B, -8.5%/yr average growth. Net income is $906M (loss), growing at -494%/yr. Net profit margin is -45.4% (negative). Gross margin is 56.2% (+1.3 pp trend).
Balance sheet: total debt is $2.7B against $3.1B equity (Debt-to-Equity (D/E) ratio 0.87, moderate). Current ratio is 2.54 (strong liquidity). Debt-to-assets is 39.2%. Total assets: $6.9B.
Analyst outlook: 14 / 29 analysts rate TFX as buy (48%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 78/100 (Pass), Growth 15/100 (Fail), Past 75/100 (Partial), Health 50/100 (Partial), Moat 70/100 (Pass), Future 40/100 (Partial), Income 10/100 (Fail).
